As already announced this afternoon, I consider today's sell-off at $BNTX (+1,57 %) is totally exaggerated. There are 16 pipeline candidates in phases 2 and 3, the first of which are to be brought to market maturity this year. And I haven't read anywhere that the two founders are taking them with them and $BNTX (+1,57 %) only making COVID vaccines again. The two founders are researchers in heart and soul. And they will also develop new innovative MRNA-based drugs with their new company. But at this stage, what is needed $BNTX (+1,57 %) first and foremost managers who can monetize the successes and understand marketing and, ideally, also have good contacts in the industry in order to enter into further collaborations. Then there will be even more deals like the one with $BMY (+2,42 %) .

That's why I thought about selling my shares at lunchtime today (illogical at first glance, I know) and buying a derivative with a factor of 10 instead, as I think the return will be significantly higher.